Drug profile · INN
indacaterol
ONBREZ
indacaterol (ONBREZ) is a beta-2 adrenergic receptor agonist. Associated with Novartis Pharmaceuticals.
EMA: approved TGA: approved Respiratory system (R03) R03AK
Patents linked 0
Pipeline programs 8
News articles 0
Drug details — indacaterol
- Class
- Respiratory system (R03)
- Route
- —
- Patents
- 0
- Programs
- 8
- Data quality
- 0.83
Quick answer
indacaterol (ONBREZ) is a beta-2 adrenergic receptor agonist. Associated with Novartis Pharmaceuticals.
Key facts
INN indacaterol
Brand ONBREZ
Mechanism Beta-2 adrenergic receptor agonist
Therapeutic class Respiratory system (R03)
ATC code R03AK
Originator Novartis Pharmaceuticals
Mechanism of action
Beta-2 adrenergic receptor agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is indacaterol?
indacaterol (ONBREZ) is a beta-2 adrenergic receptor agonist. Associated with Novartis Pharmaceuticals.
What is the brand name for indacaterol?
ONBREZ is a marketed brand name for indacaterol. Check FDA Drugs@FDA for the current US label holder and prescribing information.